These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38960969)

  • 1. Nonspecific stress biomarkers for mortality prediction in older emergency department patients presenting with falls: a prospective multicenter observational study.
    Terhalle L; Arntz L; Hoffmann F; Arnold I; Hafner L; Picking-Pitasch L; Zuppinger J; Delport Lehnen K; Leuppi J; Somasundaram R; Nickel CH; Bingisser R
    Intern Emerg Med; 2024 Jul; ():. PubMed ID: 38960969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning.
    Nickel CH; Messmer AS; Geigy N; Misch F; Mueller B; Dusemund F; Hertel S; Hartmann O; Giersdorf S; Bingisser R
    Acad Emerg Med; 2013 Jul; 20(7):670-9. PubMed ID: 23859580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study.
    Dres M; Hausfater P; Foissac F; Bernard M; Joly LM; Sebbane M; Philippon AL; Gil-Jardiné C; Schmidt J; Maignan M; Treluyer JM; Roche N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1047-1056. PubMed ID: 28408815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of different biomarkers for cardiovascular death in unselected older patients in the emergency department.
    Bahrmann P; Christ M; Hofner B; Bahrmann A; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2016 Dec; 5(8):568-578. PubMed ID: 26483565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does mid-regional pro-adrenomedullin (MR-proADM) improve the sequential organ failure assessment-score (SOFA score) for mortality-prediction in patients with acute infections? Results of a prospective observational study.
    Haag E; Gregoriano C; Molitor A; Kloter M; Kutz A; Mueller B; Schuetz P
    Clin Chem Lab Med; 2021 May; 59(6):1165-1176. PubMed ID: 33554514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department.
    Nickel CH; Ruedinger J; Misch F; Blume K; Maile S; Schulte J; Köhrle J; Hartmann O; Giersdorf S; Bingisser R
    Acad Emerg Med; 2011 Aug; 18(8):851-9. PubMed ID: 21843221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
    Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
    Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
    Krüger S; Ewig S; Giersdorf S; Hartmann O; Suttorp N; Welte T;
    Am J Respir Crit Care Med; 2010 Dec; 182(11):1426-34. PubMed ID: 20639437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenomedullin for Risk Stratification of Emergency Patients With Nonspecific Complaints: An Interventional Multicenter Pilot Study.
    Nickel CH; Messmer AS; Ghanim L; Ilsemann-Karakoumis J; Giersdorf S; Hertel S; Ernst S; Geigy N; Bingisser R
    Medicine (Baltimore); 2016 Jan; 95(1):e2395. PubMed ID: 26735540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study.
    Montrucchio G; Sales G; Balzani E; Lombardo D; Giaccone A; Cantù G; D'Antonio G; Rumbolo F; Corcione S; Simonetti U; Bonetto C; Zanierato M; Fanelli V; Filippini C; Mengozzi G; Brazzi L
    Front Med (Lausanne); 2023; 10():1122367. PubMed ID: 37035317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections.
    Baumann P; Fuchs A; Gotta V; Ritz N; Baer G; Bonhoeffer JM; Buettcher M; Heininger U; Szinnai G; Bonhoeffer J;
    PLoS One; 2022; 17(3):e0264305. PubMed ID: 35271609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification using D-dimers in patients presenting to the emergency department with nonspecific complaints.
    Nickel CH; Kuster T; Keil C; Messmer AS; Geigy N; Bingisser R
    Eur J Intern Med; 2016 Jun; 31():20-4. PubMed ID: 27053291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study.
    Saeed K; Wilson DC; Bloos F; Schuetz P; van der Does Y; Melander O; Hausfater P; Legramante JM; Claessens YE; Amin D; Rosenqvist M; White G; Mueller B; Limper M; Callejo CC; Brandi A; Macchi MA; Cortes N; Kutz A; Patka P; Yañez MC; Bernardini S; Beau N; Dryden M; van Gorp ECM; Minieri M; Chan L; Rood PPM; Del Castillo JG
    Crit Care; 2019 Feb; 23(1):40. PubMed ID: 30736862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midregional proadrenomedullin safely reduces hospitalization in a low severity cohort with infections in the ED: a randomized controlled multi-centre interventional pilot study.
    Gonzalez Del Castillo J; Clemente-Callejo C; Llopis F; Irimia A; Oltra-Hostalet F; Rechner C; Schwabe A; Fernandez-Rodriguez V; Sánchez-Mora C; Giol-Amich J; Prieto-García B; Bardés-Robles I; Ortega-de Heredia MD; García-Lamberechts EJ; Navarro-Bustos C;
    Eur J Intern Med; 2021 Jun; 88():104-113. PubMed ID: 33906810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients.
    Indirli R; Bandera A; Valenti L; Ceriotti F; Di Modugno A; Tettamanti M; Gualtierotti R; Peyvandi F; Montano N; Blasi F; Costantino G; Resi V; Orsi E; Arosio M; Mantovani G; Ferrante E;
    Eur J Clin Invest; 2022 May; 52(5):e13753. PubMed ID: 35128648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin.
    Sozio E; Moore NA; Fabris M; Ripoli A; Rumbolo F; Minieri M; Boverio R; Rodríguez Mulero MD; Lainez-Martinez S; Martínez Martínez M; Calvo D; Gregoriano C; Williams R; Brazzi L; Terrinoni A; Callegari T; Hernández Olivo M; Esteban-Torrella P; Calcerrada I; Bernasconi L; Kidd SP; Sbrana F; Miguens I; Gordon K; Visentini D; Legramante JM; Bassi F; Cortes N; Montrucchio G; Di Lecce VN; Lauritano EC; García de Guadiana-Romualdo L; González Del Castillo J; Bernal-Morell E; Andaluz-Ojeda D; Schuetz P; Curcio F; Tascini C; Saeed K
    Respir Res; 2022 Aug; 23(1):221. PubMed ID: 36031619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Hartmann O; Morgenthaler NG; Anker SD
    J Am Coll Cardiol; 2011 Aug; 58(10):1057-67. PubMed ID: 21867843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of physiological stress markers at the emergency department to readmission and death within 90 days: a prospective observational study.
    Davidson LT; Schilling UM; Arnqvist HJ; Nystrom FH; Chisalita SI
    Ups J Med Sci; 2023; 128():. PubMed ID: 37223634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
    Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
    Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department].
    Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Sicilia-Bravo I; Palomo-de Los Reyes MJ; Cabezas-Martínez A; Laín-Terés N; Estebaran-Martín J; Lozano-Ancín A; Cuena-Boy R
    Enferm Infecc Microbiol Clin; 2014 Apr; 32(4):225-35. PubMed ID: 24182623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.